Literature DB >> 21308504

Topical antibiotic therapy of chronic rhinosinusitis.

Richard H Comstock1, Kent Lam, Suzette Mikula.   

Abstract

Many different treatment options for chronic rhinosinusitis (CRS) exist, but questions remain regarding the best options. Although oral and intravenous antimicrobial therapies have traditionally been prescribed to manage CRS, topical administration of these agents has gained increasing popularity over the past few years. Topical antimicrobial agents are preferable because of their ability to localize delivery to the sinonasal mucosa and minimize the systemic effects seen with oral agents. This quality is especially important in treatment of biofilms, where higher concentrations of antibiotics are usually required. This article gives a brief overview of CRS and provides a summary of recent studies using topical agents for treatment of bacterial and fungal sinusitis.

Entities:  

Year:  2010        PMID: 21308504     DOI: 10.1007/s11908-010-0085-4

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  44 in total

1.  Surgical outcomes in rhinosinusitis: what we know.

Authors:  J D Osguthorpe
Journal:  Otolaryngol Head Neck Surg       Date:  1999-04       Impact factor: 3.497

Review 2.  Pathogenesis of chronic rhinosinusitis: role of airborne fungi and bacteria.

Authors:  Laura J B Davis; Hirohito Kita
Journal:  Immunol Allergy Clin North Am       Date:  2004-02       Impact factor: 3.479

3.  Evaluation of the in vivo efficacy of topical tobramycin against Pseudomonas sinonasal biofilms.

Authors:  Alexander G Chiu; Marcelo B Antunes; James N Palmer; Noam A Cohen
Journal:  J Antimicrob Chemother       Date:  2007-04-03       Impact factor: 5.790

Review 4.  Role of fungus in eosinophilic sinusitis.

Authors:  Jan Gosepath; Wolf J Mann
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2005-02       Impact factor: 2.064

5.  Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial.

Authors:  Jens U Ponikau; David A Sherris; Amy Weaver; Hirohito Kita
Journal:  J Allergy Clin Immunol       Date:  2005-01       Impact factor: 10.793

Review 6.  Clinical outcomes after endoscopic sinus surgery.

Authors:  Neil Bhattacharyya
Journal:  Curr Opin Allergy Clin Immunol       Date:  2006-06

7.  The diagnosis and incidence of allergic fungal sinusitis.

Authors:  J U Ponikau; D A Sherris; E B Kern; H A Homburger; E Frigas; T A Gaffey; G D Roberts
Journal:  Mayo Clin Proc       Date:  1999-09       Impact factor: 7.616

8.  Chronic rhinosinusitis and biofilms.

Authors:  Hassan H Ramadan; Jose A Sanclement; John G Thomas
Journal:  Otolaryngol Head Neck Surg       Date:  2005-03       Impact factor: 3.497

Review 9.  Palliative care for the patient with refractory chronic rhinosinusitis.

Authors:  Elizabeth J Mahoney; Ralph Metson
Journal:  Otolaryngol Clin North Am       Date:  2009-02       Impact factor: 3.346

10.  Use of nebulized antibiotics for acute infections in chronic sinusitis.

Authors:  Winston C Vaughan; Gerard Carvalho
Journal:  Otolaryngol Head Neck Surg       Date:  2002-12       Impact factor: 3.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.